David Kass

David Kass

Dr. David Kass has published articles in corporate finance, industrial organization, and health economics. He currently teaches Advanced Financial Management and Business Finance, and is the Faculty Champion for the Sophomore Finance Fellows. Prior to joining the faculty of the Smith School in 2004, he held senior positions with the Federal Government (Federal Trade Commission, General Accounting Office, Department of Defense, and the Bureau of Economic Analysis). Dr. Kass has recently appeared on Bloomberg TV, CNBC, PBS Nightly Business Report, Maryland Public Television, Business News Network TV (Canada), FOX TV, Bloomberg Radio, Wharton Business Radio, KCBS Radio, American Public Media's Marketplace Radio, and WYPR Radio (Baltimore), and has been quoted on numerous occasions by The Wall Street Journal, Bloomberg News, The New York Times and The Washington Post, where he has primarily discussed Warren Buffett, Berkshire Hathaway, the economy, and the stock market. 

Five Ways Verizon Wins With Yahoo

Verizon’s $4.8 billion cash purchase of Yahoo positions the telecom giant to fulfill its longstanding goal to be a player in online media and advertising, says Smith School marketing professor P.K. Kannan. Meanwhile, Smith School professor David Kass says Berkshire Hathaway investors have given the deal a vote of confidence, which bodes well for Verizon's value and stock prices. Read more...

An Unexpected Buying Opportunity for Berkshire

What do you do if you lose $7 billion in one week following the Brexit vote? If you’re Warren Buffett and his portfolio managers at Berkshire Hathaway, you go shopping. “With over $60 billion of cash on Berkshire's balance sheet, it’s likely they invested some of these funds in individual stocks they had been following, which would have become more attractive after this sudden decline,” Smith School finance professor David Kass says. Read more...

Making Sense of Berkshire’s Bite of Apple

Berkshire Hathaway’s small but much-discussed bite of Apple suggests a vote of confidence for a tech giant that had been sliding in the stock market. It also hints at how Warren Buffett’s holding company will do business after the 85-year-old "Oracle of Omaha" no longer is there, Smith School professor David Kass says. Revealed Monday in a regulatory filing, the roughly $1 billion investment of 9.8 million shares represents about 1 percent of Berkshire’s $129 billion portfolio value. Read more...

Insights from Buffett's Analysis of 2008 Financial Crisis

Clinical professor of finance David Kass is a Berkshire Hathaway shareholder and a close follower of Warren Buffett’s investment strategy since 1980. He says the recent release of a 103-page "Financial Crisis Inquiry Commission Interview of Warren Buffett" provides "interesting insights into the causes of the financial crisis, its consequences on the shareholders of financial institutions, and on stock market valuation.” Read more...

Backlash Against Eye-Popping Drug Prices

Martin Shkreli became the Internet villain of the fall (some publications used much harsher language) when his company, Turing Pharmaceuticals, acquired the rights to Daraprim, which treats a condition called toxoplasmosis — and promptly raised the per-pill price from $13.50 to $750. The move was entirely legal, but a bipartisan U.S. Senate committee is looking into what one senator called "price gouging" in the industry. Read more...

A Consumer Goods Behemoth Faces Pressure

Is it time for the biggest consumer products group in the world to be broken up? Procter & Gamble may account for more than half of the market for laundry care in the United States (Tide, Gain, Downy), more than two-thirds of the market for razors and blades (Gillette), and 15.5 percent of the beauty and personal care market (Pantene, and on and on). That's added up to a market capitalization of more than $200 billion. But P&G’s sales have dropped by nearly 9 percent since 2012. Smith School professor David Kass shares insights. Read more...

Pages

Subscribe to RSS - David Kass